About Your Child's Care and Condition
Our team of experienced children’s cancer professionals is nationally-ranked for pediatric cancer care. We are actively involved in research to further understand brain tumors in children and are proud to be at the forefront of advanced personalized medicine, with national collaborations moving this research forward. We offer a multidisciplinary, weekly pediatric brain tumor conference, which includes pediatric oncologists, neurologists, neurosurgeons and other pediatric medical specialists. Together, we can help your child get through treatment with as few side effects as possible. This makes us uniquely positioned to provide hope and support for children with brain tumors such as gliomas and medulloblastomas.
In addition to the expertise of our team here, our pediatric oncology research program leads the Beat Childhood Cancer consortium, which includes 33 hospitals across the United States. Within the consortium, we enrolled 203 children in our pediatric cancer clinical trials in 2017. These trials are based on the research from collaborating investigators who are linked with laboratory programs developing novel therapies and technologies. This means we can offer your child and family leading-edge treatments for his or her specific genetic analysis that are showing the most encouraging results.
Brain tumors are the second most common form of childhood cancer. Medulloblastoma is a type of brain tumor. Gliomas are tumors that occur in the brain and spinal cord. A brain tumor begins when healthy cells in the brain change and grow out of control, forming a mass. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Symptoms depend on a child's age and the location of the tumor, but may include headache, vomiting, slurred speech, vision changes, seizures and balance problems.